4 0% Last mo
5 years ago
New River Management
OpusPoint Partners, Iroquois Capital, Downsview Capital, Kingsbridge Capital, Rosalind Capital Partners, Rockmore Capital, Dafna Capital Management, Brio Capital, Sigma-Tau
Use Soligenix's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Soligenix's historical Linkedin followers to better understand their social media traction over time.
Use Soligenix's mobile downloads and app ranks to evaluate the performance of their mobile apps.
Soligenix (SNGX) Rating Downgraded at H.C. Wainwright to “Neutral” with $2.7 Target Price per Share
Contrasting Epirus Biopharmaceuticals (EPRS) and Soligenix (SNGX)
Soligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23082017 Prices from USD $250
Soligenix Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 11062017 Prices from USD $350
Maxim Group Reiterates $5.0 TP On Soligenix (NASDAQ:SNGX), Reiterates “Buy” Rating